Skip to content

Change in patient‐centered outcomes of psychological well‐being, sleep, and suicidality following treatment with intravenous ketamine for late‐life treatment‐resistant depression

Benjamin Vanderschelden, M. A. Gebara, H. Oughli, M. Butters, Patrick J. Brown, Nuri B Farber, A. Flint, J. Karp, H. Lavretsky, Benoit H. Mulsant, C. Reynolds, S. Roose, Eric J Lenze

International Journal of Geriatric Psychiatry July 1, 2023 DOI: 10.1002/gps.5964 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Population Older adults with late-life treatment-resistant depression
Intervention Intravenous ketamine
Topics Depression Esketamine Ketamine
Citations 13
Key findings Intravenous ketamine improved psychological well-being and sleep but did not improve suicidality in older adults with treatment-resistant depression.

Abstract

To examine whether psychological well‐being, sleep, and suicidality improved with treatment with intravenous (IV) ketamine for late‐life treatment‐resistant depression (TRD).

Comparable studies

Other observational and cohort studies on ketamine for depression, most cited first.

Study Year Design Participants
Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder Patients with treatment-resistant major depressive disorder 2012 Observational cohort n = 30
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome Healthy controls and actively depressed patients with treatment-resistant depression... 2017 Observational cohort n = 59
Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression Treatment-resistant inpatients with DSM-IV-TR-diagnosed major depressive disorder or... 2014 Post hoc analysis of pooled data from four studies n = 108
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression Drug-free patients with major depressive disorder 2011 Observational cohort n = 14
Efficacy of ketamine therapy in the treatment of depression Drug-free/naïve men with severe depression, no history of psychotic disorder, head... 2019 Observational cohort n = 25

Explore topics

By condition and practice